Press release
Animal Drug Compounding Market to Cross US$ 4.03 Bn in revenues by 2031-end
Animal Drug Compounding Market
๐ง๐ต๐ฒ ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐ฎ๐ป๐ถ๐บ๐ฎ๐น ๐ฑ๐ฟ๐๐ด ๐ฐ๐ผ๐บ๐ฝ๐ผ๐๐ป๐ฑ๐ถ๐ป๐ด ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ฎ๐ ๐๐ฎ๐น๐๐ฒ๐ฑ ๐ฎ๐ ๐จ๐ฆ$ ๐ญ.๐ด๐ฐ ๐๐ป ๐ถ๐ป ๐ฎ๐ฌ๐ฎ๐ญ, ๐ฎ๐ป๐ฑ ๐ถ๐ ๐ฒ๐ ๐ฝ๐ฒ๐ฐ๐๐ฒ๐ฑ ๐๐ผ ๐ด๐ฟ๐ผ๐ ๐ฎ๐ซ ๐ฏ๐ ๐ฎ๐ฌ๐ฏ๐ญ. ๐ง๐ต๐ฒ ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ณ๐ผ๐ฟ ๐ฎ๐ป๐ถ๐บ๐ฎ๐น ๐ฑ๐ฟ๐๐ด ๐ฐ๐ผ๐บ๐ฝ๐ผ๐๐ป๐ฑ๐ถ๐ป๐ด ๐๐ผ๐น๐๐๐ถ๐ผ๐ป๐ ๐ถ๐ ๐๐ฒ๐ ๐๐ผ ๐๐ถ๐๐ป๐ฒ๐๐ ๐ฎ ๐ต๐ถ๐ด๐ต ๐ด๐ฟ๐ผ๐๐๐ต ๐ฟ๐ฎ๐๐ฒ ๐ผ๐ณ ๐ด.๐ฎ% ๐ฎ๐ป๐ฑ ๐ฟ๐ฒ๐ฎ๐ฐ๐ต ๐จ๐ฆ$ ๐ฐ.๐ฌ๐ฏ ๐๐ป ๐ฏ๐ ๐ฎ๐ฌ๐ฏ๐ญ.
The market expanded at 5.8% during 2016 through 2021, owing to growing demand for customized compounded products over commercially available products.
๐ฅ๐ฒ๐พ๐๐ฒ๐๐ ๐ณ๐ผ๐ฟ ๐๐ฟ๐ฒ๐ฒ ๐ฆ๐ฎ๐บ๐ฝ๐น๐ฒ ๐๐ผ๐ฝ๐ ๐ผ๐ณ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐@ https://www.persistencemarketresearch.com/samples/12871
According to Persistence Market Research, making up close to one-third of the global market share. In the world market for compounding pharmacies in 2021, animal medication compounding held a nearly 18% share.
The range of treatment requirements in veterinary medicine is sizably broad, and the number of licenced medication items for all veterinary species and indications is sizably constrained. As a result, animal medication compounding is crucial to bridging the therapeutic gap for these non-human species.
When acceptable, government-approved goods are not readily available, compounded drugs offer numerous therapy for animals. Certain species are advised to utilise commercially approved medications in certain dose forms, such as chewable pills that should not be administered to cats or other domesticated animals.
The flavour of some commercially available goods might also turn some animals off. In this situation, compounding is preferred, especially for those medications that are challenging to treat.
๐๐๐ฒ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ-
โข ๐๐จ๐ฒ๐'๐ฌ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ
โข ๐๐๐ซ๐ญ๐ข๐ฌ๐ข๐ฌ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ
โข ๐๐ฆ๐ข๐ญ๐ก ๐๐๐ฅ๐๐ฐ๐๐ฅ๐ฅ ๐๐ซ๐ฎ๐ ๐๐ญ๐จ๐ซ๐
โข ๐๐ข๐ฑ๐ญ๐ก ๐๐ฏ๐๐ง๐ฎ๐ ๐๐๐๐ข๐๐๐ฅ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ
โข ๐๐จ๐ฎ๐ ๐ก๐๐ซ๐ญ๐ฒ'๐ฌ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ
โข ๐๐ซ๐ข๐๐ง๐ ๐ฅ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ ๐๐ง๐.
โข ๐๐๐๐ข๐ฌ๐๐ ๐๐ง๐.
โข ๐๐๐๐ ๐๐ฐ๐จ๐จ๐ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ
โข ๐๐ข๐ฅ๐ฅ๐๐ซ๐ฌ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ
โข ๐๐ก๐ข๐ซ๐จ๐ง ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ
โข ๐๐๐๐ ๐๐๐ง๐๐๐ข๐๐ง ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ
โข ๐๐ฎ๐ซ๐จ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐
โข ๐๐๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ
โข ๐๐ข๐๐ญ๐จ๐ซ๐ข๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ
โข ๐๐ซ๐๐ญ๐ญ'๐ฌ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ
โข ๐๐๐จ๐ฉ๐ฅ๐'๐ฌ ๐๐ก๐จ๐ข๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ ๐๐ง๐ ๐ฆ๐จ๐ซ๐
๐๐ฒ๐ ๐๐๐น๐น ๐๐ฐ๐ฐ๐ฒ๐๐ ๐ผ๐ณ ๐๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ฎ๐ป๐ฑ ๐๐ฒ๐ ๐จ๐ฝ ๐๐ผ ๐ฎ๐ฌ% ๐๐ถ๐๐ฐ๐ผ๐๐ป๐@ https://www.persistencemarketresearch.com/checkout/12871
๐๐๐ฒ ๐๐๐ ๐ฆ๐๐ง๐ญ๐ฌ: ๐๐ง๐ข๐ฆ๐๐ฅ ๐๐ซ๐ฎ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ฎ๐ซ๐ฏ๐๐ฒ
๐๐ง๐ข๐ฆ๐๐ฅ ๐๐ซ๐ฎ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ:
CNS Agents
Anti-Infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
๐๐ง๐ข๐ฆ๐๐ฅ ๐๐ซ๐ฎ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐ง๐ข๐ฆ๐๐ฅ ๐๐ฒ๐ฉ๐:
Companion Animals
Livestock Animals
๐๐ง๐ข๐ฆ๐๐ฅ ๐๐ซ๐ฎ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐ ๐จ๐ซ๐ฆ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง:
Injectable Animal Drugs
Oral Animal Drugs
Others
๐๐ง๐ข๐ฆ๐๐ฅ ๐๐ซ๐ฎ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐๐ ๐ข๐จ๐ง:
North America Animal Drug Compounding Market
Latin America Animal Drug Compounding Market
Europe Animal Drug Compounding Market
South Asia Animal Drug Compounding Market
East Asia Animal Drug Compounding Market
Oceania Animal Drug Compounding Market
Middle East & Africa Animal Drug Compounding Market
๐ฌ๐ผ๐ ๐๐ฎ๐ป ๐๐๐๐๐ผ๐บ๐ถ๐๐ฒ ๐๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐๐ ๐ฝ๐ฒ๐ฟ ๐ฌ๐ผ๐๐ฟ ๐ฅ๐ฒ๐พ๐๐ถ๐ฟ๐ฒ๐บ๐ฒ๐ป๐ ๐๐น๐ถ๐ฐ๐ธ ๐๐ฒ๐ฟ๐ฒ@https://www.persistencemarketresearch.com/request-customization/12871
๐๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐๐ฒ ๐๐ฎ๐ป๐ฑ๐๐ฐ๐ฎ๐ฝ๐ฒ
Veterinary companies operating in the animal drug compounding space actively follow strategies such as signing partnership and acquisition agreements to enhance their penetration and gain revenue share in the market. Leading animal drug compounding providers are adopting attractive strategies that would drive their product demand in the market.
For instance, in December 2020, Wedgewood Pharmacy and Partners Group signed a definitive purchase agreement that will replace New Harbor Capital as its majority shareholder.
About Us:
Persistence Market Research's Expertise in Life Sciences and Transformational Health:Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
Contact Us:
Persistence market research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Animal Drug Compounding Market to Cross US$ 4.03 Bn in revenues by 2031-end here
News-ID: 2879599 • Views: โฆ
More Releases from Persistence Market Research Pvt. Ltd
Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Mar โฆ
Stroke Rehabilitation Market Size
The global stroke rehabilitation market size was valued at US$ 266.4 million in 2021 and is expected to grow at a CAGR of 9% from 2022 to 2032. Revenue generated from the sales of stroke rehabilitation solutions will surge to US$ 679.6 Million by the end of 2032.
The growth of the market is being driven by the increasing incidence of strokes, the growing demand for innovative rehabilitationโฆ
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthe โฆ
Market Study on Aesthetic Lasers
The aesthetic lasers market reached US$2.8 billion in global revenue in 2021, and it will continue to expand quickly, with a value CAGR of 6.4%, to reach US$5.5 billion by the end of 2032. The growth of the market is being driven by the increasing demand for minimally invasive cosmetic procedures, rising disposable income, technological advancements, and growing medical tourism.
Stay Ahead with Market Intelligence Get Freeโฆ
Predictive Insights for Precision Medicine: The Global Biosimulation Market is S โฆ
Biosimulation Market Research
The Global Biosimulation Market Size was valued at USD 2.9 billion in 2022 and is expected to reach USD 10.0 billion by 2030, registering a CAGR of 16.9% during the forecast period. The growth of the biosimulation market is being driven by the increasing use of biosimulation in a variety of applications, such as drug discovery, clinical trials, and toxicity prediction.ย
Market Overview
The biosimulation market has experienced rapid growthโฆ
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheel โฆ
Wheelchair and Components Market
The global wheelchair and components market is projected to reach USD 17.9 billion by 2033, at a CAGR of 3.7% from 2022-2033. The growth of the market is driven by the increasing prevalence of disabilities, the rising geriatric population, and technological advancements in wheelchair design and manufacturing.
Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12961
The global wheelchair and components market has witnessed significant growth inโฆ
More Releases for Animal
Animal Health Market Sets the Table for Continued Growth : Zoetis Animal Healthc โฆ
Advance Market Analytics published a new research publication on "Animal Health Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Health market was mainly driven by the increasing R&D spending across the world. Some of the key players profiledโฆ
Animal Antimicrobials and Antibiotics Market 2023 Growth and Development By Bion โฆ
Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Animal Antimicrobials and Antibiotics includes Premixes, Oral Powders, Oral Solutions and Injections on the base of classification, which represent 12.4%, 14.4%, 10.4% and 56.6% of global Animal Antimicrobials and Antibiotics market.
Get Sample Copy: https://www.worldwidemarketreports.com/sample/273708
Farm Animals and Companion Animals are theโฆ
Animal Healthcare Market Analysis Focusing on Top Key Players - Merck, Bayer Ani โฆ
Worldwide Market Reports recently released on the Animal Healthcare market for the forecast period, 2017 โ 2022 is involved in screening the business environment and the companies operating in the Animal Healthcare industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on the basis ofโฆ
Animal Model Market trends, Animal Model Market growth, Animal Model Market size โฆ
Key Findings of Animal Model Market
Developing Regions to Overpower Developed Ones With Regard to Demand
The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, theirโฆ
Animal Growth Promoter Market Outlook To 2023 โ Bayer Animal Health, Biomin, B โฆ
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,โฆ
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer โฆ
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this reportโฆ
